Five such companies which have firmed up their initial public offering (IPO) plans are Glenmark Lifesciences, a fully-owned arm of Glenmark Pharmaceuticals, the city-based bulk drugs firm Supriya Lifesciences, drug formulations firm Windlass Biotech, Bain Capital-backed Emcure Pharma and CX Partners-funded Veeda Clinical Research. According to investment-bankers, they are planning to mop up over Rs 7,000 crore in primary share sales.
Sensex: Sensex, Nifty close at lifetime highs; mid & smallcap indices gain over 1 5% as buying returns to broader market indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
sensex: Sensex rebounds to end 125 pts higher; metals, PSU banks cap upside indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Asian shares were trading with mild gains on Thursday, shrugging off the worries about coronavirus infections and mixed overnight trade on Wall Street. MSCI s broadest index of Asia-Pacific shares outside Japan was up by 0.15 per cent.